Skip to main content
. 2019 Mar 29;10:634. doi: 10.3389/fimmu.2019.00634

Figure 5.

Figure 5

Undifferentiated naïve cardiac ILCs transiently express PLZF upon activation. (A) Timeline of PLZF+Ki67+ activation pattern under in vitro ILC2-differentiating conditions, IL-2+IL-7+IL-33. (B) Progression of GATA3 expression, showing the gate of GATA3+ ILCs. (C) Time course of ILC2 phenotype development, based on KLRG1 and ST2 co-expression. (D) Graph representing the evolution of the PLZF+Ki67+ co-expression. (E) Timeline of GATA3 expression during in vitro IL-33 stimulation. (F) Time curve showing the progression of ILC2 phenotype development. (G) Curve showing the evolution of IL-5 (blue) and IL-13 (red) production under IL-2+IL-7+IL-33 stimulation, as measured by ELISA of supernatants. Graphics show results of 1 of 2 independent experiments, each one made in triplicates for each condition. Asterisks represent the statistical significance of each time-point with respect to day 1-baseline values. Dots and whiskers show Mean and SD. Statistics calculated with one-way ANOVA and Bonferroni post-test. *P < 0.05; **P < 0.01; ***P < 0.001.